Tacrolimus
FDA Approved
Description
Tacrolimus is an immunosuppressant drug used to prevent organ rejection after transplantation. It is also used off-label for certain autoimmune conditions.
Indications & Therapeutic Use
Organ transplant rejection prophylaxis, Atopic dermatitis, Steroid-resistant nephrotic syndrome
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Tacrolimus
| Generic Name | Tacrolimus |
| Brands | 1 brand available |
| Active Ingredient | Tacrolimus |
| Drug Class | Organ transplant rejection prophylaxis |
| Manufacturer | Astellas Pharma |
| Dosage Forms | Capsule, Tablet, IV solution |
| Medical Code | L04AD02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT04104801 |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes